<DOC>
	<DOCNO>NCT02973646</DOCNO>
	<brief_summary>The study observe anti-HBV therapeutic effect peginterferon alfa-2b chronic hepatitis b patient e antigen positive base detection interferon gene mutation ( IFNA2 p.Ala120Thr ) interferon receptor ( IFNAR2 ) detection .</brief_summary>
	<brief_title>Peginterferon Alfa-2b Treatment HBeAg ( + ) Chronic Hepatitis b Patients Based Interferon Gene Mutation Receptor Detection</brief_title>
	<detailed_description>Patients e antigen positive chronic hepatitis b enrol study . Age , sex , symptom ( e.g. , fever , fatigue , poor appetite , jaundice ) record study . We also observe laboratory test result include level white blood cell ( WBC ) , red blood cell ( RBC ) , hemoglobin ( HGB ) , platelet ( PLT ) , alanine transaminase ( ALT ) , aspartate transaminase ( AST ) , hepatitis B surface antigen ( HBsAg ) , hepatitis B e antigen ( HBeAg ) , hepatitis B e antibody ( HBeAb ) , hepatitis B virus ( HBV ) DNA ; detection gene mutation ( IFNA2 p.Ala120Thr ) , level interferon receptor ( IFNAR2 ) .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Peginterferon alfa-2b</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Entecavir</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>1 . Chronic hepatitis b Patients receive antiHBV therapy accord guideline willing receive interferon therapy ; 2 . Hepatitis B e antigen positive . 1 . Patients receive antiHBV therapy past 6 month ; 2 . Patients liver cirrhosis hepatocellular carcinoma malignancy ; 3 . Patients factor cause active liver disease ; 4 . Pregnancy lactation woman ; 5 . Patients HIV infection congenital immune deficiency disease ; 6 . Patients severe diabetes , autoimmune disease , important organ dysfunction serious complication . 7 . Patients reason suitable receive interferon therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>chronic hepatitis b</keyword>
	<keyword>peginterferon alfa-2b</keyword>
	<keyword>interferon gene mutation</keyword>
	<keyword>interferon receptor</keyword>
</DOC>